Military Medical Research
Military Medical Research is an open-access, peer-reviewed journal published by KeAi Publishing and affiliated with the Committee of Medical Science and Technology of the Chinese PLA, founded in 2014, devoted to modern military medicine, with a 2025 Journal Impact Factor of 29.0《军事医学研究》是由科爱(KeAi)出版、依托中国人民解放军医学科学技术委员会的开放获取同行评审期刊,2014 年创刊,专注现代军事医学,2025 年影响因子为 29.0。
Scope
- It is an open-access, peer-reviewed journal disseminating the latest evidence and findings across the full range of basic and clinical sciences该刊是开放获取的同行评审期刊,传播基础与临床医学各个领域的最新证据与发现。
- Its focus is modern military medicine, spanning translational research, precision medicine and emerging interdisciplinary subjects其焦点是现代军事医学,涵盖转化研究、精准医学与新兴交叉学科。
- It welcomes basic medical research with translational potential and clinical research relevant to modern warfare and peacetime military operations该刊欢迎具转化潜力的基础医学研究,以及与现代化战争和平时军事行动相关的临床研究。
- Topic areas include combat casualty care and field surgery, field internal medicine, and nuclear, biological and chemical medicine主题领域包括战创伤救治与野战外科、野战内科,以及核化生医学。
- It also covers special-environment medicine, aerospace and maritime medicine, military mental health and military health logistics该刊也涉及特殊环境医学、航天与航海医学、军事心理学以及军事卫勤学。
- Article types include editorials, research highlights, perspectives, original articles, reviews and letters to the editor文章类型包括述评、研究热点、观点、原创论文、综述与致编辑信函。[1]
History
- The journal was founded in 2014, with its first issue formally launched in March 2014 and its online edition following in April 2014该刊于 2014 年创刊,首期于 2014 年 3 月正式创刊,网络版于 2014 年 4 月上线。
- It was launched as an English-language platform to bring Chinese military medical research to an international audience该刊作为英文平台创办,旨在把中国军事医学研究推向国际读者。
- Volumes 1 to 12 were published with BioMed Central (BMC), part of Springer Nature第 1 至第 12 卷由生物医学中心(BioMed Central,BMC)出版,属施普林格·自然(Springer Nature)旗下。
- From volume 13 in 2026 the journal has been published by KeAi Publishing, a joint venture of Science Press and Elsevier自 2026 年第 13 卷起,该刊改由科爱(KeAi)出版,后者是科学出版社与爱思唯尔(Elsevier)的合资公司。
- The Committee of Medical Science and Technology of the PLA, established in 1954, is its society affiliate中国人民解放军医学科学技术委员会(成立于 1954 年)是该刊的学会归属单位。
- Its 2025 Journal Impact Factor is 29.0, ranking sixth among 336 general and internal medicine journals in the SCIE edition其 2025 年影响因子为 29.0,在 SCIE 版 336 种全科与内科学期刊中排名第六。
Editors
- The editor-in-chief is Xiao-Bing Fu of the Chinese PLA General Hospital现任主编为 Xiao-Bing Fu,任职于中国人民解放军总医院。
- He is a member of the Chinese Academy of Engineering and a leading expert in trauma repair and regenerative medicine他是中国工程院院士,也是创伤修复与再生医学领域的领军专家。
- The executive editors-in-chief are Chen-Fang Fan of the Academy of Military Sciences and Yong-Ming Yao of the Chinese PLA General Hospital执行主编为军事科学院的 Chen-Fang Fan 与中国人民解放军总医院的 Yong-Ming Yao。
- Qing-Jie Li serves as honorary editor-in-chief and is president of the Committee of Medical Science and Technology of the PLA荣誉主编为 Qing-Jie Li,他同时担任中国人民解放军医学科学技术委员会主任委员。
- Associate editors include researchers from the Academy of Military Medical Sciences副编辑包括来自军事医学研究院(Academy of Military Medical Sciences)的研究人员。
- All manuscripts undergo peer review, and the journal charges authors no fee because the article processing charge is covered by the editorial office所有稿件均经同行评审,且该刊不向作者收取费用,因文章处理费由编辑部承担。
References
- ^Guo Y R, Cao Q D, Hong Z S, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Military Medical Research, 2020, 7:11. doi:10.1186/s40779-020-00240-0